Clinical Trial Update: Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of diclofenac diethylamine 2.32% gel in patients with acute ankle sprain (Grade I/II); results were posted aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain

Drugs mentioned

• Diclofenac diethylamine 2.32% gel (diclofenac diethylamine gel)

Snippet

Sponsor: Novartis | Conditions: Grade I/II Ankle Sprain | Phase 3 | Status: COMPLETED | Results posted: 2011-01-26